Rebecca Taub
2017
In 2017, Rebecca Taub earned a total compensation of $1.1M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
| Bonus | $247,900 |
|---|---|
| Salary | $370,000 |
| Stock Awards | $473,337 |
| Other | $558 |
| Total | $1,091,795 |
Taub received $473.3K in stock awards, accounting for 43% of the total pay in 2017.
Taub also received $247.9K in bonus, $370K in salary and $558 in other compensation.
Rankings
In 2017, Rebecca Taub's compensation ranked 8,570th out of 14,666 executives tracked by ExecPay. In other words, Taub earned more than 41.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,570 out of 14,666 | 42nd |
Division Manufacturing | 3,251 out of 5,770 | 44th |
Major group Chemicals And Allied Products | 1,085 out of 2,074 | 48th |
Industry group Drugs | 859 out of 1,730 | 50th |
Industry Pharmaceutical Preparations | 670 out of 1,329 | 50th |
Source: SEC filing on April 27, 2018.
Taub's colleagues
We found two more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2017.